Ads
related to: scholarly articles on multiple sclerosis disease- Treatment FAQs
See Frequently Asked
Questions. Get The Answers.
- Financial Resources
See Financial & Savings Info.
Learn About Savings Options.
- Patient Resources
Download Resources To
Learn More About Treatment.
- Patient Stories
See What Real Patients
Are Saying About This Treatment.
- Relapsing MS Treatment
Learn About A RMS
Treatment Option.
- Taking RMS Treatment
Watch A Video On How The
Treatment Is Taken.
- Treatment FAQs
Search results
Results From The WOW.Com Content Network
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis .
Multiple sclerosis. Multiple sclerosis is an autoimmune disease, primarily mediated by T-cells. [15] The three main characteristics of MS are the formation of lesions in the central nervous system (also called plaques), inflammation, and the destruction of myelin sheaths of neurons.
In March 2017, ocrelizumab was approved in the United States for the treatment of primary progressive multiple sclerosis in adults. [22] [42] It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [42]
Myelin sheath of a healthy neuron in the central nervous system. Multiple sclerosis is an inflammatory demyelinating disease of the CNS in which activated immune cells invade the central nervous system and cause inflammation, neurodegeneration, and tissue damage.
Multiple sclerosis is considered a disease of the white matter because normally lesions appear in this area, but it is also possible to find some of them in the grey matter. [ 30 ] Using high field MRI system, with several variants several areas show lesions, and can be spacially classified in infratentorial, callosal, juxtacortical ...
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. [67] The importance of this discovery is that the expression of these genes appears in blood and can be measured by a simple blood analysis. NR1H3 Mutation.
Ads
related to: scholarly articles on multiple sclerosis disease